EnVVeno Medical Q4 EPS $(0.32) Beats $(0.46) Estimate
EnVVeno Medical Q4 EPS $(0.32) Beats $(0.46) Estimate
EnvVeno Medical第四季度每股收益美元（0.32）超過預期（0.46）
enVVeno Medical (NASDAQ:NVNO) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.46) by 30.43 percent. This is a 41.82 percent increase over losses of $(0.55) per share from the same period last year.
EnvVeno Medical（納斯達克股票代碼：NVNO）公佈的季度虧損爲每股0.32美元，比分析師共識估計的美元（0.46美元）高出30.43個百分點。這比去年同期每股虧損0.55美元（0.55）增長了41.82％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。